Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancer

Journal of Endourology

Volumn 19, Issue 3, 2005, Pages 318-326

  Soderdahl, Douglas W ^a,b   Davis, John W ^a   Schellhammer, Paul F ^a,b   Given, Robert W ^a,b   Lynch, Donald F ^a,b   Shaves, Mark ^a   Burke, Bonnie L ^a   Fabrizio, Michael D ^a  

^a Department of Urology ^*  (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PALLADIUM 103;

ADULT; AGED; ARTICLE; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; INSTRUMENT; INTESTINE FUNCTION; LAPAROSCOPIC SURGERY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RADIOISOTOPE THERAPY; SCORING SYSTEM; SEXUAL FUNCTION; TREATMENT PLANNING; URINARY TRACT FUNCTION;

ADULT; AGED; ANALYSIS OF VARIANCE; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LAPAROTOMY; LONGITUDINAL STUDIES; MALE; MARKOV CHAINS; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RISK ASSESSMENT; SICKNESS IMPACT PROFILE; TIME FACTORS; TREATMENT OUTCOME;

EID: 18544372456     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2005.19.318     Document Type: Article

References (33)

1. Guillonneau B, el Fettouh H, Baumert H, et al. Laparoscopic radical prostatectomy: Oncological evaluation after 1000 cases at Montsouris Institute. J Urol 2003;169:1261.
2. Walsh PC. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: A structured debate. J Urol 2000;163:1802.
3. Ragde H, Elgamal AAA, Snow PB, et al. Ten-year disease-free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized low to high Gleason grade prostate carcinoma. Cancer 1998;83:989.
4. Efficace F, Bottomley A, Osoba D, et al. Beyond the development of health-related quality of life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials: Does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol 2003;21:3502.
5. McCammon KA, Kolm P, Main B, et al. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999;54:509.
6. Litwin MS, Lubeck DP, Henning JM, et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. J Urol 1998;159:1988.
7. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I: Conceptual framework and item selection. Med Care 1993;30:473.
8. Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 1998;36:1002.
9. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 1992;148:1549.
10. Penson DF, Litwin MS, Aaronson NK. Health related quality of life in men with prostate cancer. J Urol 2003;169:1653.
11. Clark JA, Inui TS, Silliman RA, et al. Patients' perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol 2003;21:3777.
12. Davis JW, Kuban DA, Lynch DF, et al. Quality of life after treatment for localized prostate cancer: Differences based on treatment modality. J Urol 2001;166:947.
13. Lim AJ, Brandon AH, Fiedler J, et al. Quality of life: Radical prostatectomy versus radiation therapy for prostate cancer. J Urol 1995;154:1420.
14. Brandeis JM, Litwin MS, Burnison CM, et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 2000;163:851.
15. Penson DF, Feng Z, Kuniyuki A, et al. General quality of life 2 years following treatment for prostate cancer: What influences outcomes? Results from the Prostate Cancer Outcomes Study. J Clin Oncol 2003;21:1147.
16. Hollenbeck BK, Dunn RL, Wei JT, et al. Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol 2003;169:1453.
17. Litwin MS, Melmed GY, Nakazon T. Life after radical prostatectomy: A longitudinal study. J Urol 2001;166:587.
18. Litwin MS, Pasta DJ, Yu J, et al. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: A longitudinal, multivariate quality of life analysis form the cancer of the prostate strategic urologic research endeavor. J Urol 2000;164: 1973.
19. Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 2003;21:3979.
20. Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002;20:557.
21. Hara I, Kawabata G, Miyake H, et al. Comparison of quality of life following laparoscopic and open prostatectomy for prostate cancer. J Urol 2003;169:2045.
22. Downs TM, Sadetsky M, Pasta DJ, et al. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer: Data from CaPSURE. J Urol 2003;170:1822.
23. Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899.
24. Nelson JB. Is brachytherapy a kinder gentler treatment for prostate cancer? J Urol 2004;171:1109.
25. Grills IS, Martinez AA, Hollander M, et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 2004;171:1098.
26. Miller DC, Sandler H, Wei JT. Complications of permanent interstitial brachytherapy for carcinoma of the prostate. AUA Update Series 2004;23(2):9.
27. Tzu-Cheg K, Cruess DF, Garner D, et al. Multi-center patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy. J Urol 2000;163:858.
28. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 2000;283:354.
29. Catalona WJ, Carvalhal GF, Mager DE, et al. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999;162:433.
30. Walsh PC, Marschke, Ricker D, et al. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000;55:58.
31. Hu JC, Elin EP, Pasta DJ, et al. Predicting quality of life after radical prostatectomy: Results from CaPSURE. J Urol 2004;171:703.
32. Krupski TL, Saigal CS, Litwin MS. Variation in continence and potency by definition. J Urol 2003;170:1291.
33. Gralnek D, Wessels H, Cui H, et al. Differences in sexual function and quality of life after nerve sparing and non-nerve sparing radical retropubic prostatectomy. J Urol 2000;163:1166.